Privia Health Q1 Revenue Seen at $580.65M, EPS $0.08; Full-Year Forecast Upgraded
PRVA•Privia Health is scheduled to report Q1 2026 results on May 7, with consensus revenue of $580.65 million and EPS of $0.08. Analysts have raised full-year revenue forecasts to $2.47 billion and EPS to $0.35, while 2027 revenue projections increased to $2.73 billion and EPS estimates rose to $0.46.
1. Q1 2026 Earnings Preview
Privia Health will report Q1 2026 earnings on May 7, with analysts projecting revenue of $580.65 million and EPS of $0.08, reflecting expectations for continued top-line growth in its physician-enabled care model.
2. Upward Estimate Revisions
Over the past 90 days full-year 2026 revenue forecasts climbed from $2.38 billion to $2.47 billion and EPS estimates from $0.32 to $0.35, while 2027 revenue projections rose from $2.59 billion to $2.73 billion and EPS forecasts went from $0.42 to $0.46.
3. Q4 2025 Performance
In Q4 2025 Privia Health reported $541.17 million in revenue, missing the $565.54 million consensus by 4.31%, and delivered EPS of $0.07, beating the $0.04 estimate; shares jumped nearly 10% the day after the release.
4. Analyst Price Targets and Ratings
Seventeen analysts set an average one-year price target of $31.76, suggesting about 30.6% upside from current levels, while GuruFocus estimates imply a GF Value of $31.57 and brokerage firms maintain an average Outperform recommendation (1.8).
